Published: Wed, April 05, 2017
Finance | By Laverne Griffith

Mylan announces nationwide EpiPen recall

Mylan announces nationwide EpiPen recall

Officials say the recalled product was manufactured by Meridian Medical Technologies and distributed by Mylan between December 2015 and January 2016.

The recall is due to the potential that these devices may contain a defective part that may result in the devices' failure to activate.

Mylcan called the defect "extremely rare", and is recalling 13 lots of the pens.

Pharmaceutical company Mylan has announced a nationwide, voluntary recall of certain lots of EpiPen and EpiPen Jr. due to a possible defect.

Some EpiPen autoinjectors have reportedly not quite been autoinjecting as they're supposed to, prompting the parent company to voluntarily initiate a far-reaching product recall.

'Bathroom bill' could cost North Carolina more NCAA events
An AP analysis this week found that HB2 already will cost the state more than $3.76 billion in lost business over a dozen years. The two votes brought together unusual bedfellows of legislators in support of, or opposition to, the HB2 repeal initiative.

Trump recycles campaign fodder to distract from Russia
Schiff said Trump himself tried to shift Congress' focus away from that core mission of foreign intervention. No elected official, including from Trump's Republican Party, has supported the claim.

Zidane suggests Varane's injury issues may be playing on his mind
Real Madrid stayed atop of the Primera Division table with a 3-0 victory over Alaves at the Santiago Bernabeu. On the other end, Alaves is in the 10th position with 40 points.

EpiPens are used to give an emergency injection of epinephrine to treat life-threatening allergic reactions. Mylan will replacing any of the affected devices free of charge. The easiest way to check if your product is included is by first checking the expiration date - if your devices expire in April, May, October, or November 2017, check the lot number against this chart. Mylan bought the EpiPen product in 2007 and then continued to raise the price of the product over the decade to follow-upwards of 600 percent-arguing that maintaining consistent quality of the product was a major reason for the significant price hikes.

"The expanded voluntary recall is being initiated in the US and also will extend to additional markets in Europe, Asia, North and South America", Mylan said in a statement.

For more information about the recall, visit the Health Canada website.

Mylan CEO Heather Bresch was even called to testify in front of Congress a year ago, though she lied about things like how much the company was making on the product.

Like this: